Prognoses of Patients With Melanoma Who Continue/Discontinue Anti–PD-1 Therapy After Achieving a Complete Response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study
Br J Dermatol 2022 Mar 29;[EPub Ahead of Print], J Kato, K Namikawa, J Uehara, M Nomura, Y Nakamura, H Uhara, H Uchi, S Yoshikawa, Y Kiniwa, Y Nakamura, T Miyagawa, S Matsushita, T Takenouchi, N Hatta, F Ohno, T Maeda, S Fukushima, N YamazakiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.